Anacor Pharma: Palo Alto company posts disease of the skin study results San Jose Mercury News AP Anacor Pharmaceuticals is reporting affirmative results from a mid-stage trial of a drug candidate designed to delicacy the skin condition disease of the skin . Anacor said Mon that the drug ablated psoriasis plaques by xxvi percent after six weeks of the 12-week ... Anacor Pharmaceuticals Announces affirmative Preliminary Results from state of matter 2b ... MarketWatch (press release) Anacor Pharmaceuticals INC Announces Positive Preliminary Results From Phase ... BioMedReports (subscription) all 42 tidings articles » Link To Article
No comments:
Post a Comment